3,5-diiodothyropropionic acid has been researched along with Heart Failure in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anand, I; Barnhill, J; Churby, L; Dunlap, M; Edson, R; Erikson, J; Goldman, S; Hattler, B; Ladenson, PW; Lavori, P; McCarren, M; Morkin, E; O'Brien, T; Ohm, J; Shih, MC; Thai, H; Warner, A; Warren, S | 1 |
| Anand, I; Barnhill, JG; Churby, L; Dunlap, M; Edson, RG; Erikson, J; Goldman, S; Hattler, B; Ladenson, PW; McCarren, M; Morkin, E; O'Brien, T; Shih, MC; Thai, H; Warner, A; Warren, SR | 1 |
| Gerdes, MA; Iervasi, G; Pingitore, A | 1 |
| Gerdes, AM; Iervasi, G | 1 |
| Arsanjani, R; Bahl, JJ; Goldman, S; McCarren, M | 1 |
| Bahl, JJ; Goldman, S; Morkin, E; Pennock, G; Spooner, PH; Underhill Fox, K | 1 |
| Bahl, JJ; Goldman, S; Morkin, E; Pennock, GD; Spooner, PH | 1 |
| Gaballa, MA; Goldman, S; Spooner, PH; Thai, HM | 1 |
| Adamson, C; Goldman, S; Ladenson, P; Morkin, E | 1 |
| Adamson, C; Bahl, JJ; Goldman, S; Greer, K; Hoying, J; Klewer, S; Maitra, N; Morkin, E | 1 |
| Bahl, JJ; Goldman, S; Morkin, E; Pennock, GD; Raya, TE | 3 |
| Gabel, M; Hoit, BD; Pawloski-Dahm, CM; Shao, Y; Walsh, RA | 1 |
| Goldman, S; Morkin, E; Spooner, PH | 1 |
| Litwin, SE; Pennock, GD; Spooner, PH; Summers, CE | 1 |
6 review(s) available for 3,5-diiodothyropropionic acid and Heart Failure
| Article | Year |
|---|---|
Thyroid replacement therapy and heart failure.
Topics: Animals; Cardiovascular Diseases; Diiodothyronines; Disease Models, Animal; Glomerular Filtration Rate; Heart Failure; Homeostasis; Humans; Hyperthyroidism; Hypothyroidism; Kidney Tubules; Muscle Cells; Myocardial Contraction; Myocardial Infarction; Natriuretic Peptides; Propionates; Thyroid Hormones; Thyroxine; Triiodothyronine; Vasodilation | 2010 |
Translational potential of thyroid hormone and its analogs.
Topics: Animals; Calcium Signaling; Cardiotonic Agents; Contractile Proteins; Diiodothyronines; Heart; Heart Failure; Humans; Myocardial Contraction; Potassium; Propionates; Randomized Controlled Trials as Topic; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Thyroid Hormones; Translational Research, Biomedical | 2011 |
Clinical and experimental studies on the use of 3,5-diiodothyropropionic acid, a thyroid hormone analogue, in heart failure.
Topics: Animals; Captopril; Cholesterol; Clinical Trials as Topic; Diiodothyronines; Disease Models, Animal; Dose-Response Relationship, Drug; Double-Blind Method; Heart Failure; Hemodynamics; Humans; Myocardial Infarction; Pilot Projects; Propionates; Rabbits; Randomized Controlled Trials as Topic; Rats; Treatment Outcome; Triglycerides | 2002 |
Thyroid hormone analogs for treatment of hypercholesterolemia and heart failure: past, present and future prospects.
Topics: Animals; Anticholesteremic Agents; Diiodothyronines; Heart Failure; Humans; Hypercholesterolemia; Mitochondria; Propionates; Rats; Thyroid Hormones | 2004 |
Development of a thyroid hormone analogue for the treatment of congestive heart failure.
Topics: Animals; Cardiotonic Agents; Diiodothyronines; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Heart Failure; Humans; Myocardial Contraction; Myocardial Infarction; Propionates; Rabbits; Rats; Triiodothyronine; Ventricular Function, Left | 1996 |
Thyroid hormone and thyroid hormone analogues in the treatment of heart failure.
Topics: Animals; Diiodothyronines; Disease Models, Animal; Heart Failure; Humans; Propionates; Thyroid Hormones | 1999 |
4 trial(s) available for 3,5-diiodothyropropionic acid and Heart Failure
| Article | Year |
|---|---|
DITPA (3,5-Diiodothyropropionic Acid), a thyroid hormone analog to treat heart failure: phase II trial veterans affairs cooperative study.
Topics: Adolescent; Adult; Aged; Body Weight; Cholesterol; Diiodothyronines; Double-Blind Method; Fatigue; Female; Gastrointestinal Diseases; Heart Failure; Humans; Lipoproteins, LDL; Male; Middle Aged; Propionates; Thyroid Hormones; United States; United States Department of Veterans Affairs; Vascular Resistance | 2009 |
Effects of the thyromimetic agent diiodothyropropionic acid on body weight, body mass index, and serum lipoproteins: a pilot prospective, randomized, controlled study.
Topics: Aged; Body Mass Index; Body Weight; Chronic Disease; Diiodothyronines; Dose-Response Relationship, Drug; Double-Blind Method; Heart Failure; Humans; Lipoproteins; Middle Aged; Osteogenesis; Patient Selection; Pilot Projects; Propionates; Prospective Studies; Thyrotropin; Thyroxine; Time Factors; Treatment Outcome; Triiodothyronine | 2010 |
Pilot studies on the use of 3,5-diiodothyropropionic acid, a thyroid hormone analog, in the treatment of congestive heart failure.
Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Diiodothyronines; Dose-Response Relationship, Drug; Double-Blind Method; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Pilot Projects; Propionates; Thyroid Hormones; Thyrotropin; Time Factors; Treatment Outcome; Ventricular Function, Left | 2002 |
Clinical and experimental studies on the use of 3,5-diiodothyropropionic acid, a thyroid hormone analogue, in heart failure.
Topics: Animals; Captopril; Cholesterol; Clinical Trials as Topic; Diiodothyronines; Disease Models, Animal; Dose-Response Relationship, Drug; Double-Blind Method; Heart Failure; Hemodynamics; Humans; Myocardial Infarction; Pilot Projects; Propionates; Rabbits; Randomized Controlled Trials as Topic; Rats; Treatment Outcome; Triglycerides | 2002 |
7 other study(ies) available for 3,5-diiodothyropropionic acid and Heart Failure
| Article | Year |
|---|---|
Letter by Pingitore et al regarding article, "DITPA (3,5-diiodothyropropionic acid), a thyroid hormone analog to treat heart failure: phase II trial Veterans Affairs cooperative study".
Topics: Clinical Trials, Phase II as Topic; Diiodothyronines; Heart Failure; Humans; Propionates; Thyroid Hormones | 2010 |
Thyroid hormone analog, DITPA, improves endothelial nitric oxide and beta-adrenergic mediated vasorelaxation after myocardial infarction.
Topics: Acetylcholine; Animals; Cattle; Cells, Cultured; Coronary Vessels; Diiodothyronines; Endothelium, Vascular; Heart Failure; Hemodynamics; Isoproterenol; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroprusside; Propionates; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Vasodilator Agents; Ventricular Function, Left | 2004 |
Regulation of gene expression in rats with heart failure treated with the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA) and the combination of DITPA and captopril.
Topics: Animals; Captopril; Cardiotonic Agents; Diiodothyronines; Drug Therapy, Combination; Gene Expression Regulation; Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+); Heart Failure; Heart Rate; Male; Mitochondrial Proteins; Mitochondrial Proton-Translocating ATPases; Myocardial Infarction; Propionates; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Transcriptional Activation; Ventricular Function, Left | 2007 |
Studies on the use of thyroid hormone and a thyroid hormone analogue in the treatment of congestive heart failure.
Topics: Animals; Captopril; Cardiac Output; Cattle; Diiodothyronines; Heart Failure; Hemodynamics; Humans; Propionates; Rats; Receptors, Thyroid Hormone; Triiodothyronine | 1993 |
Combination treatment with captopril and the thyroid hormone analogue 3,5-diiodothyropropionic acid. A new approach to improving left ventricular performance in heart failure.
Topics: Animals; Captopril; Diiodothyronines; Drug Therapy, Combination; Heart Failure; Hemodynamics; Male; Myocardial Infarction; Propionates; Rats; Rats, Sprague-Dawley; Ventricular Function, Left | 1993 |
The effects of a thyroid hormone analog on left ventricular performance and contractile and calcium cycling proteins in the baboon.
Topics: Animals; Calcium; Calcium-Transporting ATPases; Diiodothyronines; Heart Failure; Heart Rate; Male; Myocardial Contraction; Myocardium; Myosin Heavy Chains; Papio; Propionates; Sarcoplasmic Reticulum; Thyroid Hormones; Ventricular Function, Left | 1997 |
Prevention of abnormal sarcoplasmic reticulum calcium transport and protein expression in post-infarction heart failure using 3, 5-diiodothyropropionic acid (DITPA).
Topics: Adenosine Triphosphate; Animals; Biological Transport, Active; Calcium; Calcium Signaling; Cardiotonic Agents; Diiodothyronines; Drug Evaluation, Preclinical; Echocardiography; Gene Expression Regulation; Heart; Heart Failure; Hemodynamics; Ion Transport; Ligation; Membrane Proteins; Muscle Proteins; Myocardial Infarction; Myocardium; Organ Size; Propionates; Rabbits; RNA, Messenger; Sarcoplasmic Reticulum | 2000 |